Amyloid Protein Biochemist Project Scientist – Glabe Lab
Open date: May 15, 2023
Most recent review date: Tuesday, May 30, 2023 at 11:59pm (Pacific Time)
Applications received after this date will be reviewed by the search committee if the position has not yet been filled.
Final date: Sunday, Dec 31, 2023 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
The Department of Molecular Biology and Biochemistry in the School of Biological Sciences is accepting applications in the area protein biochemistry / structural biology related to Alzheimer’s disease. The person in the position will perform experiments with human brain samples and transgenic mice and amyloid fibrils and oligomers formed from synthetic and recombinant purified proteins under the direction of Dr. Charles Glabe. This NIH-funded project aims at developing methods for the purification and preparation of homogeneous amyloid oligomers and fibrils of different structural polymorphs and tools for studying amyloid polymorphism in vitro and in vivo. The hypothesis to be examined is that different types of amyloid accumulate in different phenotypic variants of disease. The researcher also will work on the seeded aggregation and replication of these amyloids isolated from human brain. Renewal of the appointment will be contingent on the availability of adequate funding and performance.
The University of California, Irvine is ranked among the nation’s best research institutes with over $90,000,000 in current funding. Enrichment opportunities abound through the Alzheimer’s Disease Research Center, the Memory Impairment and Neurodegenerative Disease Institute and the Center for the Neurobiology of Learning and Memory. Irvine has a pleasant climate, five miles from the beach.
Candidate demonstrates significant, original, and creative contribution to a research or creative program or project, demonstrates professional competency and activity, performing university and public service is encouraged.
• Ph.D. in biochemistry, cell biology or biophysics with experience in protein biochemistry is required.
• Experience working with amyloids and insoluble proteins and proteomic analysis are preferred.
Qualified candidates should submit their curriculum vitae, a cover letter, and the names and contact information of three references.
Accepting all applicants.
Curriculum Vitae - Your most recently updated C.V.
Statement of Research (Optional)
Misc / Additional (Optional)
Sexual Misconduct, Harassment and Discrimination Declaration Form - All applicants of academic positions at the University of California, Irvine must download, complete, sign, and upload the following form with their application: Sexual Misconduct, Harassment and Discrimination Declaration Form
- 3-5 required (contact information only)
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.